EFFECTS OF SEASON ON STRATUM CORNEUM 203 (67) P. W. Wertz, Lipids and barrier function of the skin, Acta. Derm. Venereol. Suppl. (Stockh), 208, 7–11 (2000). (68) K. Akimoto, N. Yoshikawa, Y. Higaki, M. Kawashima, and G. Imokawa, Quantitative analysis of stra- tum corneum lipids in xerosis and asteatotic eczema, J. Dermatol., 20, 1–6 (1993). (69) A. W. Fulmer and G. J. Kramer, Stratum corneum lipid abnormalities in surfactant-induced dry scaly skin, J. Invest. Dermatol., 86, 598–602 (1986). (70) A. di Nardo, P. Wertz, A. Giannetti, and S. Seidenari, Ceramide and cholesterol composition of the skin of patients with atopic dermatitis, Acta. Derm. Venereol., 78, 27–30 (1998). (71) G. Imokawa, Lipid abnormalities in atopic dermatitis, J. Am. Acad. Dermatol., 45, S29–S32 (2001). (72) M. Janssens, J. van Smeden, G. S. Gooris, W. Bras, G. Portale, P. J. Caspers, R. J. Vreeken, T. Hankemeier, S. Kezic, R. Wolterbeek, A. P. Lavrijsen, and J. A. Bouwstra, Increase in short-chain ceramides corre- lates with an altered lipid organization and decreased barrier function in atopic eczema patients, J. Lipid Res., 53, 2755–2766 (2012). (73) M. Janssens, J. van Smeden, G. S. Gooris, W. Bras, G. Portale, P. J. Caspers, R. J. Vreeken, S. Kezic, A. P. Lavrijsen, and J. A. Bouwstra, Lamellar lipid organization and ceramide composition in the stra- tum corneum of patients with atopic eczema, J. Invest. Dermatol., 131, 2136–2138 (2011). (74) J. van Smeden, M. Janssens, E. C. Kaye, P. J. Caspers, A. P. Lavrijsen, R. J. Vreeken, and J. A. Bouwstra, The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients, Exp. Dermatol., 23, 45–52 (2014). (75) M. Farwick, P Lersch, B. Santonnat, K. Korevaar, and A. V. Rawlings, Developments in ceramide iden- tifi cation, synthesis, function and nomenclature, Cosmetics Toiletries, 124, 63–72 (2009). (76) J. Ishikawa, H. Yoshida, S. Ito, A. Naoe, T. Fujimura, T. Kitahara, Y. Takema, C. Zerweck, and G. L. Grove, Dry skin in the winter is related to the ceramide profi le in the stratum corneum and can be im- proved by treatment with a Eucalyptus extract, J. Cosmet. Dermatol., 12, 3–11 (2013). (77) J. A. Bouwstra, G. S. Gooris, F. E. Dubbelaar, A. M. Weerheim, A. P. Ijzerman, and M. Ponec, Role of ceramide 1 in the molecular organization of the stratum corneum lipids, J. Lipid Res., 39, 186–196 (1998). (78) E. H. Mojumdar, Z. Kariman, L. van Kerckhove, G. S. Gooris, and J. A. Bouwstra, The role of ceramide chain length distribution on the barrier properties of the skin lipid membranes, Biochim. Biophys. Acta., 1838, 2473–2483 (2014). (79) E. Zettersten, M. Q. Man, J. Sato, M. Denda, A. Farrell, R. Ghadially, M. L. Williams, K. R. Feingold, and P. M. Elias, Recessive x-linked ichthyosis: role of cholesterol-sulfate accumulation in the barrier abnormality, J. Invest. Dermatol., 111, 784–790 (1998). (80) J. Sato, M. Denda, J. Nakanishi, J. Nomura, and J. Koyama, Cholesterol sulfate inhibits proteases that are involved in desquamation of stratum corneum, J. Invest. Dermatol., 111, 189–193 (1998).